 Analgesics, Opioid
"Analgesics, Opioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.
| Descriptor ID |
D000701
|
| MeSH Number(s) |
D27.505.696.663.850.014.520 D27.505.954.427.040.325 D27.505.954.427.210.049
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Analgesics, Opioid".
Below are MeSH descriptors whose meaning is more specific than "Analgesics, Opioid".
This graph shows the total number of publications written about "Analgesics, Opioid" by people in this website by year, and whether "Analgesics, Opioid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 2 | 0 | 2 | | 1993 | 0 | 1 | 1 | | 1995 | 1 | 0 | 1 | | 1996 | 3 | 0 | 3 | | 1997 | 2 | 1 | 3 | | 1998 | 2 | 1 | 3 | | 1999 | 3 | 2 | 5 | | 2000 | 4 | 1 | 5 | | 2001 | 0 | 1 | 1 | | 2002 | 4 | 2 | 6 | | 2003 | 0 | 2 | 2 | | 2004 | 2 | 3 | 5 | | 2005 | 4 | 2 | 6 | | 2006 | 1 | 1 | 2 | | 2007 | 4 | 2 | 6 | | 2008 | 6 | 0 | 6 | | 2009 | 1 | 0 | 1 | | 2010 | 3 | 2 | 5 | | 2011 | 5 | 2 | 7 | | 2012 | 4 | 0 | 4 | | 2013 | 4 | 4 | 8 | | 2014 | 11 | 4 | 15 | | 2015 | 4 | 4 | 8 | | 2016 | 9 | 1 | 10 | | 2017 | 6 | 1 | 7 | | 2018 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Analgesics, Opioid" by people in Profiles.
-
Grundmann O, Brown PN, Boyer EW, Swogger MT, Walsh Z, Prozialeck W, Kruegel AC, Veltri CA, Dudley S. Critique of "Kratom Use and Toxicities in the United States". Pharmacotherapy. 2019 11; 39(11):1119-1120.
-
Liebschutz JM, Lange AV, Heymann OD, Lasser KE, Corey P, Shanahan CW, Kopinski HS, Husain JM, Cushman PA, Parker VA. Communication between nurse care managers and patients who take opioids for chronic pain: Strategies for exploring aberrant behavior. J Opioid Manag. 2018 May/Jun; 14(3):191-202.
-
Chai PR, Carreiro S, Innes BJ, Chapman B, Schreiber KL, Edwards RR, Carrico AW, Boyer EW. Oxycodone Ingestion Patterns in Acute Fracture Pain With Digital Pills. Anesth Analg. 2017 12; 125(6):2105-2112.
-
Romero-Gonzalez M, Shahanaghi A, DiGirolamo GJ, Gonzalez G. Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders. Am J Addict. 2017 Dec; 26(8):838-844.
-
Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, Guara G, O'Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial. JAMA Intern Med. 2017 Sep 01; 177(9):1265-1272.
-
Garcia C, Lefkowits C, Pelkofski E, Blackhall L, Duska LR. Prospective screening with the validated Opioid Risk Tool demonstrates gynecologic oncology patients are at low risk for opioid misuse. Gynecol Oncol. 2017 11; 147(2):456-459.
-
Tran S, Lavitas P, Stevens K, Greenwood BC, Clements K, Alper CJ, Lenz K, Price M, Hydery T, Arnold JL, Takeshita M, Bacon R, Peristere JP, Jeffrey PL. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population. J Manag Care Spec Pharm. 2017 May; 23(5):532-539.
-
Cushman PA, Liebschutz JM, Hodgkin JG, Shanahan CW, White JL, Hardesty I, Alford DP. What do providers want to know about opioid prescribing? A qualitative analysis of their questions. Subst Abus. 2017 Apr-Jun; 38(2):222-229.
-
Salas J, Scherrer JF, Schneider FD, Sullivan MD, Bucholz KK, Burroughs T, Copeland LA, Ahmedani BK, Lustman PJ. New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation. Pain. 2017 02; 158(2):306-312.
-
Scherrer JF, Salas J, Sullivan MD, Schneider FD, Bucholz KK, Burroughs T, Copeland L, Ahmedani B, Lustman PJ. The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med. 2016 10; 91:110-116.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|